Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative with Evident Efficacy in Patients with Muscle Invasive Bladder Cancer
The Comparison of Intravesical Therapy and Surgery as Treatment Options CISTO for Bladder Cancer Study
A Phase III Randomized Trial of Eribulin NSC 707389 with Gemcitabine Versus Standard of Care Physician's Choice for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy
Study Type: Treatment
Phase: III
NCTID: NCT04579224
Principal Investigator:
Saqib Abbasi
LaserEn: SOLTIVE? Thulium Laser Fiber En Bloc Resection of Bladder Tumors
METRICS Study: Metabolic Evaluation Through Resting Indirect Calorimetry in Bladder Cancer
Study Type: Supportive Care
Phase: N/A
NCTID: NCT06721260
Principal Investigator:
Jill Hamilton-Reeves
A Phase II study of TAS-102 in metastatic Platinum and checkpoint inhibitor?resistant bladder cancer
A Randomized Open-Label Phase II/III Study of BT8009 as Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer Duravelo-2
A Phase I/II Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC Patients who are BCG Na�ve or Received Incomplete BCG Treatment LEGEND STUDY
A Phase III, Randomized Study of Adjuvant Cretostimogene Grenadenorepvec versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer IR-NMIBC Following Transurethral Resection of Bladder Tumor TURBT
A Randomized Phase III Double Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes
Study Type: Supportive Care
Phase: III
NCTID: NCT03757949
Principal Investigator:
Jill Hamilton-Reeves